ATAI Life Sciences NVNASDAQ:ATAI
- LAST PRICE1.5900
- TODAY'S CHANGE (%)0.0100 (0.6329%)
- Bid / Lots1.5000/ 12
- Ask / Lots1.6100/ 1
- Open / Previous Close1.6000 / 1.5800
- Day Range
- 52 Week Range
- Volume427,597
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATAI |
|---|---|---|
| 09:32 ET | 22248 | 1.59 |
| 09:34 ET | 15389 | 1.6 |
| 09:36 ET | 13477 | 1.63 |
| 09:38 ET | 2559 | 1.63 |
| 09:39 ET | 19879 | 1.63 |
| 09:41 ET | 2080 | 1.6201 |
| 09:43 ET | 2677 | 1.64 |
| 09:45 ET | 2000 | 1.6213 |
| 09:48 ET | 1622 | 1.625 |
| 09:50 ET | 3473 | 1.63 |
| 09:52 ET | 711 | 1.635 |
| 09:54 ET | 2376 | 1.64 |
| 09:56 ET | 1580 | 1.64 |
| 09:57 ET | 3507 | 1.635 |
| 09:59 ET | 3250 | 1.62 |
| 10:01 ET | 1550 | 1.635 |
| 10:03 ET | 300 | 1.635 |
| 10:06 ET | 1548 | 1.6394 |
| 10:08 ET | 7620 | 1.615 |
| 10:10 ET | 1500 | 1.61 |
| 10:12 ET | 2180 | 1.615 |
| 10:15 ET | 1062 | 1.615 |
| 10:17 ET | 400 | 1.614 |
| 10:19 ET | 13137 | 1.63 |
| 10:21 ET | 3615 | 1.62 |
| 10:24 ET | 1400 | 1.6101 |
| 10:26 ET | 1800 | 1.62 |
| 10:28 ET | 350 | 1.6169 |
| 10:30 ET | 500 | 1.62 |
| 10:32 ET | 4116 | 1.605 |
| 10:33 ET | 200 | 1.605 |
| 10:35 ET | 3200 | 1.61 |
| 10:37 ET | 100 | 1.61 |
| 10:39 ET | 200 | 1.61 |
| 10:42 ET | 2900 | 1.62 |
| 10:44 ET | 100 | 1.62 |
| 10:46 ET | 1100 | 1.62 |
| 10:48 ET | 265 | 1.62 |
| 10:50 ET | 200 | 1.62 |
| 10:51 ET | 2200 | 1.602 |
| 10:53 ET | 3100 | 1.605 |
| 10:55 ET | 2012 | 1.605 |
| 10:57 ET | 3720 | 1.6093 |
| 11:00 ET | 859 | 1.6097 |
| 11:02 ET | 544 | 1.61 |
| 11:04 ET | 700 | 1.605 |
| 11:06 ET | 300 | 1.61 |
| 11:08 ET | 100 | 1.61 |
| 11:09 ET | 200 | 1.61 |
| 11:11 ET | 100 | 1.61 |
| 11:13 ET | 100 | 1.61 |
| 11:15 ET | 100 | 1.61 |
| 11:18 ET | 200 | 1.61 |
| 11:20 ET | 100 | 1.61 |
| 11:22 ET | 100 | 1.61 |
| 11:24 ET | 1400 | 1.605 |
| 11:26 ET | 900 | 1.605 |
| 11:27 ET | 1100 | 1.605 |
| 11:29 ET | 100 | 1.61 |
| 11:31 ET | 200 | 1.61 |
| 11:33 ET | 100 | 1.61 |
| 11:36 ET | 200 | 1.61 |
| 11:38 ET | 100 | 1.61 |
| 11:40 ET | 100 | 1.61 |
| 11:42 ET | 100 | 1.61 |
| 11:44 ET | 100 | 1.61 |
| 11:45 ET | 1728 | 1.6099 |
| 11:47 ET | 100 | 1.61 |
| 11:49 ET | 1112 | 1.6099 |
| 11:51 ET | 1080 | 1.61 |
| 11:54 ET | 100 | 1.61 |
| 11:56 ET | 602 | 1.61 |
| 11:58 ET | 330 | 1.61 |
| 12:00 ET | 2146 | 1.615 |
| 12:02 ET | 400 | 1.615 |
| 12:03 ET | 100 | 1.62 |
| 12:07 ET | 100 | 1.6151 |
| 12:09 ET | 100 | 1.62 |
| 12:12 ET | 5300 | 1.62 |
| 12:14 ET | 215 | 1.62 |
| 12:18 ET | 11355 | 1.63 |
| 12:20 ET | 100 | 1.625 |
| 12:21 ET | 1014 | 1.624 |
| 12:23 ET | 6721 | 1.62 |
| 12:27 ET | 400 | 1.614 |
| 12:30 ET | 243 | 1.615 |
| 12:32 ET | 5622 | 1.61 |
| 12:34 ET | 2800 | 1.6 |
| 12:36 ET | 200 | 1.61 |
| 12:39 ET | 500 | 1.605 |
| 12:41 ET | 100 | 1.61 |
| 12:43 ET | 200 | 1.61 |
| 12:45 ET | 100 | 1.61 |
| 12:48 ET | 100 | 1.61 |
| 12:50 ET | 100 | 1.61 |
| 12:52 ET | 200 | 1.61 |
| 12:54 ET | 200 | 1.604 |
| 12:56 ET | 532 | 1.61 |
| 12:57 ET | 800 | 1.6083 |
| 12:59 ET | 6564 | 1.61 |
| 01:01 ET | 887 | 1.605 |
| 01:03 ET | 3778 | 1.6 |
| 01:08 ET | 100 | 1.6 |
| 01:12 ET | 1700 | 1.595 |
| 01:14 ET | 310 | 1.6 |
| 01:15 ET | 100 | 1.6 |
| 01:17 ET | 100 | 1.6 |
| 01:19 ET | 100 | 1.6 |
| 01:21 ET | 200 | 1.594 |
| 01:24 ET | 100 | 1.6 |
| 01:26 ET | 200 | 1.6 |
| 01:28 ET | 250 | 1.59 |
| 01:30 ET | 300 | 1.595 |
| 01:32 ET | 7628 | 1.595 |
| 01:33 ET | 100 | 1.6 |
| 01:35 ET | 4003 | 1.59 |
| 01:37 ET | 200 | 1.59 |
| 01:39 ET | 489 | 1.59 |
| 01:42 ET | 1007 | 1.59 |
| 01:44 ET | 260 | 1.59 |
| 01:46 ET | 1800 | 1.5861 |
| 01:48 ET | 800 | 1.6 |
| 01:50 ET | 1600 | 1.594 |
| 01:51 ET | 600 | 1.6 |
| 01:53 ET | 900 | 1.6 |
| 01:55 ET | 100 | 1.6 |
| 01:57 ET | 16479 | 1.59 |
| 02:00 ET | 400 | 1.5865 |
| 02:04 ET | 2456 | 1.59 |
| 02:06 ET | 1200 | 1.595 |
| 02:08 ET | 100 | 1.6 |
| 02:09 ET | 800 | 1.6 |
| 02:11 ET | 14568 | 1.595 |
| 02:13 ET | 1052 | 1.595 |
| 02:15 ET | 4520 | 1.59 |
| 02:18 ET | 2560 | 1.59 |
| 02:22 ET | 200 | 1.58 |
| 02:26 ET | 100 | 1.585 |
| 02:27 ET | 100 | 1.59 |
| 02:29 ET | 100 | 1.59 |
| 02:31 ET | 400 | 1.59 |
| 02:33 ET | 100 | 1.585 |
| 02:36 ET | 641 | 1.5801 |
| 02:38 ET | 100 | 1.585 |
| 02:40 ET | 100 | 1.585 |
| 02:42 ET | 7850 | 1.588 |
| 02:44 ET | 100 | 1.585 |
| 02:45 ET | 1214 | 1.59 |
| 02:47 ET | 2542 | 1.59 |
| 02:49 ET | 600 | 1.59 |
| 02:51 ET | 500 | 1.59 |
| 02:54 ET | 1250 | 1.59 |
| 02:56 ET | 300 | 1.595 |
| 02:58 ET | 6268 | 1.595 |
| 03:00 ET | 200 | 1.5901 |
| 03:02 ET | 200 | 1.595 |
| 03:03 ET | 200 | 1.595 |
| 03:05 ET | 600 | 1.595 |
| 03:07 ET | 100 | 1.595 |
| 03:09 ET | 960 | 1.595 |
| 03:12 ET | 100 | 1.595 |
| 03:14 ET | 300 | 1.595 |
| 03:16 ET | 678 | 1.595 |
| 03:18 ET | 100 | 1.595 |
| 03:20 ET | 716 | 1.595 |
| 03:21 ET | 2600 | 1.595 |
| 03:23 ET | 100 | 1.595 |
| 03:25 ET | 545 | 1.595 |
| 03:27 ET | 200 | 1.595 |
| 03:30 ET | 300 | 1.595 |
| 03:32 ET | 100 | 1.595 |
| 03:34 ET | 17461 | 1.59 |
| 03:36 ET | 1738 | 1.595 |
| 03:38 ET | 12705 | 1.595 |
| 03:39 ET | 519 | 1.6 |
| 03:41 ET | 300 | 1.6 |
| 03:43 ET | 2998 | 1.6 |
| 03:45 ET | 200 | 1.6 |
| 03:48 ET | 100 | 1.6 |
| 03:50 ET | 325 | 1.5999 |
| 03:52 ET | 300 | 1.6 |
| 03:54 ET | 6802 | 1.6 |
| 03:56 ET | 4348 | 1.6 |
| 03:57 ET | 1829 | 1.6 |
| 03:59 ET | 16540 | 1.59 |
Jun 26, 2024
atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference, from 7:00AM ET on Wednesday Jun 26, 2024 by Dow Jones
7:00AM ET on Wednesday Jun 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ATAI Life Sciences NV | 264.5M | -6.6x | --- |
Acrivon Therapeutics Inc | 258.4M | -3.1x | --- |
Design Therapeutics Inc | 276.8M | -5.0x | --- |
Artiva Biotherapeutics Inc | 277.3M | 0.0x | --- |
Tectonic Therapeutic Inc | 250.5M | 2.1x | --- |
Gossamer Bio Inc | 246.6M | -1.1x | --- |
Company Information
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Contact Information
- Headquarters
- Wallstrasse 16Berlin, Germany 10179
- Phone
- 892-153-9035
- Fax
- ---
Executives
- Chairman of the Supervisory Board
- Christian Angermayer
- Co-Chief Executive Officer
- Florian Brand
- Co-Chief Executive Officer
- Srinivas Rao
- Chief Financial Officer
- Anne Johnson
- Chief Medical Officer
- Rolando Gutierrez-esteinou
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $264.5M |
|---|---|
Revenue (TTM) | $277.0K |
Shares Outstanding | 167.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.24 |
Book Value | $1.46 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | 954.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -42,344.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
